These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17071010)

  • 21. Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).
    Mclaughlin T; Oscar-Berman M; Simpatico T; Giordano J; Jones S; Barh D; Downs WB; Waite RL; Madigan M; Dushaj K; Lohmann R; Braverman ER; Han D; Blum K
    J Behav Addict; 2013 Jun; 2(2):117-24. PubMed ID: 26165932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark.
    Alvala R; Alvala M; Sama V; Dharmarajan S; Ullas JV; B MR
    J Ethnopharmacol; 2013 Jul; 148(2):441-8. PubMed ID: 23628454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
    Blum K; Steinberg B; Gondre-Lewis MC; Baron D; Modestino EJ; Badgaiyan RD; Downs BW; Bagchi D; Brewer R; McLaughlin T; Bowirrat A; Gold M
    Psychol Res Behav Manag; 2021; 14():2115-2134. PubMed ID: 34949945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
    Blum K; McLaughlin T; Bowirrat A; Modestino EJ; Baron D; Gomez LL; Ceccanti M; Braverman ER; Thanos PK; Cadet JL; Elman I; Badgaiyan RD; Jalali R; Green R; Simpatico TA; Gupta A; Gold MS
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation.
    Choi EH; Yang HP; Chun HS
    Nutr Res; 2012 Mar; 32(3):218-28. PubMed ID: 22464809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).
    Blum K; Oscar-Berman M; Demetrovics Z; Barh D; Gold MS
    Mol Neurobiol; 2014 Dec; 50(3):765-96. PubMed ID: 24878765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The selfish brain: competition for energy resources.
    Fehm HL; Kern W; Peters A
    Prog Brain Res; 2006; 153():129-40. PubMed ID: 16876572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine gene predicts the brain's response to dopaminergic drug.
    Cohen MX; Krohn-Grimberghe A; Elger CE; Weber B
    Eur J Neurosci; 2007 Dec; 26(12):3652-60. PubMed ID: 18088284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of polyphenolic plant extracts for anti-obesity properties in Wistar rats.
    Boqué N; Campión J; de la Iglesia R; de la Garza AL; Milagro FI; San Román B; Bañuelos Ó; Martínez JA
    J Sci Food Agric; 2013 Mar; 93(5):1226-32. PubMed ID: 23080265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.
    Blum K; Oscar-Berman M; Giordano J; Downs B; Simpatico T; Han D; Femino J
    J Genet Syndr Gene Ther; 2012 Oct; 3(4):. PubMed ID: 23264886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of dietary supplements--biologically active substances in patients with obesity].
    Dotsenko VA; Mosiĭchuk LV
    Vopr Pitan; 2012; 81(5):33-6. PubMed ID: 23461170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming reward deficiency syndrome by the induction of "dopamine homeostasis" instead of opioids for addiction: illusion or reality?
    Blum K; Soni D; Badgaiyan RD; Baron D
    J Osteopath Med; 2022 Apr; 122(7):333-337. PubMed ID: 35411759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
    Blum K; Baron D; Lott L; Ponce JV; Siwicki D; Boyett B; Steinberg B; Modestino EJ; Fried L; Hauser M; Simpatico T; Downs BW; McLaughlin T; Hajela R; Badgaiyan RD
    Curr Psychopharmacol; 2020; 9(1):7-21. PubMed ID: 32432025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
    Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
    CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.
    Blum K; Febo M; Badgaiyan RD; Demetrovics Z; Simpatico T; Fahlke C; M OB; Li M; Dushaj K; Gold MS
    Curr Neuropharmacol; 2017; 15(1):184-194. PubMed ID: 27174576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity, attention deficit-hyperactivity disorder and the dopaminergic reward system.
    Campbell BC; Eisenberg D
    Coll Antropol; 2007 Mar; 31(1):33-8. PubMed ID: 17600916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.